Autologous bone marrow transplantation for stage IV neuroblastoma: the role of soybean agglutinin purging
Kapelushnik, J.; Nagler, A.; Or, R.; Naparstek, E.; Cividalli, G.; Aker, M.; Mehta, J.; Mumcuoglu, M.; Slavin, S.
Transplantation Proceedings 25(3): 2375-2376
1993
ISSN/ISBN: 0041-1345 PMID: 8516934 Document Number: 422282
Document emailed within 1 workday
Related Documents
Gorin, N.C.; Labopin, M.; Meloni, G.; Korbling, M.; Carella, A.; Herve, P.; Burnett, A.; Rizzoli, V.; Alessandrino, E.P.; Bjorkstrand, B. 1991: Autologous bone marrow transplantation for acute myeloblastic leukemia in Europe: further evidence of the role of marrow purging by mafosfamide. European Co-operative Group for Bone Marrow Transplantation (EBMT) Leukemia 5(10): 896-904Canals, C.; Picón, M.; Sanchez, T.; Torrico, C.; Amill, B.; Tugues, D.; Sierra, J.; Grañena, A.; Badell, I.; Brunet, S. 1994: Autologous bone marrow transplantation for acute lymphoblastic leukemia: role of bone marrow purging Progress in Clinical and Biological Research 389: 125-132
Ozsahin, H.; Fabrega, S.; Douay, L.; Barbu, V.; Gorin, N.C. 1990: Application of serum-free liquid bone marrow cultures to bone marrow purging for autologous bone marrow transplantation in acute lymphoblastic leukemia Nouvelle Revue Francaise d'Hematologie 32(5): 353-355
Kessinger, A.; Vose, J.M.; Bierman, P.J.; Armitage, J.O. 1991: High-dose therapy and autologous peripheral stem cell transplantation for patients with bone marrow metastases and relapsed lymphoma: an alternative to bone marrow purging Experimental Hematology 19(10): 1013-1016
Peters, R.H.; Brandon, C.S.; Avila, L.A.; Gale, G.R.; Stuart, R.K. 1990: Combinations of 4-hydroperoxycyclophosphamide (4-HC) and cisplatin for bone marrow purging in autologous marrow transplantation: an update Progress in Clinical and Biological Research 333: 57-68
Saarinen, U.M.; Coccia, P.F.; Gerson, S.L.; Pelley, R.; Cheung, N.K. 1985: Eradication of neuroblastoma cells in vitro by monoclonal antibody and human complement: method for purging autologous bone marrow Cancer Research 45(11 Pt 2): 5969-5975
Ball, E.D. 1988: In vitro purging of bone marrow for autologous marrow transplantation in acute myelogenous leukemia using myeloid-specific monoclonal antibodies Bone Marrow Transplantation 3(5): 387-392
Kojima, S.; Ueda, R. 1990: Ex vivo purging methods for autologous bone marrow transplantation Nihon Rinsho. Japanese Journal of Clinical Medicine 48(9): 2117-2124
Alvarnas, J.C.; Forman, S.J. 2004: Graft purging in autologous bone marrow transplantation: a promise not quite fulfilled Oncology 18(7): 867
De Rosa, L.; Montuoro, A.; Pandolfi, A.; Lanti, T.; Pescador, L.; Morara, R.; De Laurenzi, A. 1991: Immunomagnetic purging procedure for autologous bone marrow transplantation in lymphoid malignancies Haematologica 76(Suppl 1): 37-40
Stoppa, A.M.; Hirn, J.; Blaise, D.; Delaage, M.; Novakovitch, G.; Viens, P.; Capiello, M.A.; Mannoni, P.; Mawas, C.; Maraninchi, D. 1990: Autologous bone marrow transplantation for B cell malignancies after in vitro purging with floating immunobeads Bone Marrow Transplantation 6(5): 301-307
De Fabritiis, P.; Ferrero, D.; Sandrelli, A.; Tarella, C.; Meloni, G.; Pulsoni, A.; Pregno, P.; Badoni, R.; De Felice, L.; Gallo, E. 1989: Monoclonal antibody purging and autologous bone marrow transplantation in acute myelogenous leukemia in complete remission Bone Marrow Transplantation 4(6): 669-674
Seeger, R.C.; Villablanca, J.G.; Matthay, K.K.; Harris, R.; Moss, T.J.; Feig, S.A.; Selch, M.; Ramsay, N.; Reynolds, C.P. 1991: Intensive chemoradiotherapy and autologous bone marrow transplantation for poor prognosis neuroblastoma Progress in Clinical and Biological Research 366: 527-533
Reynolds, C.P.; Moss, T.J.; Seeger, R.C.; Black, A.T.; Woody, J.N. 1985: Sensitive detection of neuroblastoma cells in bone marrow for monitoring the efficacy of marrow purging procedures Progress in Clinical and Biological Research 175: 425-441
Fegan, C.; Thomas, H.; Bailey-Wood, R.; Coleman, S.; Phillips, S.; Hoy, T.; Whittaker, J.A. 1995: In vitro LAK (lymphokine activated killer) activity following autologous peripheral blood stem cell is significantly greater than that following autologous bone marrow and allogeneic bone marrow transplantation Bone Marrow Transplantation 16(2): 277-281
Hernández, M.D.; del Cañizo, M.C.; González, M.; Caballero, M.D.; López-Berges, M.C.; Vázquez, L.; Orfao, A.; Corral, M.; Nieto, M.J.; San Miguel, J.F. 1998: Immune reconstitution after autologous progenitor hemopoietic cell transplantation. a study comparing autologous bone marrow and autologous peripheral blood transplantation Medicina Clinica 110(20): 768-773
Roberts, M.M.; To, L.B.; Gillis, D.; Mundy, J.; Rawling, C.; Ng, K.; Juttner, C.A. 1993: Immune reconstitution following peripheral blood stem cell transplantation, autologous bone marrow transplantation and allogeneic bone marrow transplantation Bone Marrow Transplantation 12(5): 469-475
Rhodes, E.G.; Baker, P.K.; Duguid, J.K.; Davies, J.M.; Cawley, J.C. 1992: A method for clinical purging of myeloma bone marrow using peanut agglutinin as an anti-plasma cell agent, in combination with CD19 monoclonal antibody Bone Marrow Transplantation 10(6): 485-489
Duhamel, G.; Gorin, N.C.; Douay, L.; Najman, A.; Stachowiak, J. 1982: Bone marrow repopulation after heavy chemotherapy and autologous bone marrow transplantation. Monitoring with biopsies and marrow culture on agar La Nouvelle Presse Medicale 11(11): 833-836
Michon, J.; Négrier, S.; Coze, C.; Mathiot, C.; Frappaz, D.; Oskam, R.; Pacquement, H.; Quintana, E.; Bouffet, E.; Bernard, J.L. 1994: Administration of high-dose recombinant interleukin 2 after autologous bone marrow transplantation in patients with neuroblastoma: toxicity, efficacy and survival. a Lyon-Marseille-Curie-east of France Group Study Progress in Clinical and Biological Research 385: 293-300